Andrew Holden, M.D. discusses key outcomes including primary patency per patient and per lesion, fTLR, ABI, WIQ and Rutherford category improvement.
Learn more: https://www.goremedical.com/viabahn/d...
YouTube is a global platform, and Gore is not able to restrict certain audiences. This video is intended only for a medical professional audience in the following countries and/or regions: Australia, New Zealand (grouped), Brazil, US. It contains information on devices that have been cleared, approved, or authorized by applicable regulators in those countries/regions.